Nanotechnology has potential to revolutionise orthopaedics - experts call for research into safety
6/06/2014
"Nanotechnology holds enormous potential for orthopaedics. But the key question is, can we be sure it won't cause harm to patients over the long term?
Elucidating the pathogenic mechanism of meningococcal meningitis
6/06/2014
Neisseria meningitidis, also called meningococcus, is a bacterium responsible for meningitis and septicemia[1]. Its most serious form, purpura fulminans, is often fatal.
A 14-year-old boy's turnaround and quick recovery after mysteriously being stricken by brain-inflaming encephalitis -- which led to him being hospitalized for six weeks and put into a medically...
Researchers unravel mechanism of cell death, offering potential for treating inflammatory diseases
6/06/2014
Researchers at VIB and Ghent University have unraveled the mechanism of necroptosis.
Researchers develop search engine for identifying functionally linked genes
6/06/2014
A frontier lies deep within our cells.Our bodies are as vast as oceans and space, composed of a dizzying number of different types of cells.
Study finds public awareness of head and neck cancers low
6/05/2014
Public awareness of head and neck cancer (HNC) is low, with few Americans knowing much about risk factors such as tobacco use and human papillomavirus (HPV).
Lung cancer breath test looking more promising
6/05/2014
The feasibility of a non-invasive breath test for lung cancer has already been demonstrated. Now, a new study shows it can distinguish lung cancer from COPD and stage the cancer.
Data shows LBH589 significantly improved progression-free survival in patients with multiple myeloma
6/05/2014
Novartis presented results from a pivotal Phase III trial showing a 37% improvement in progression-free survival (PFS) when using the investigational compound LBH589 (panobinostat) in combination...
'Liquid biopsy' offers new way to track lung cancer
6/05/2014
Scientists have shown how a lung cancer patient's blood sample could be used to monitor and predict their response to treatment paving the way for personalised medicine for the disease.
AstraZeneca's Medimmune presents encouraging immunotherapy data at ASCO 2014
6/05/2014
MedImmune, the global biologics research and development arm of AstraZeneca, presented results today from its novel investigational immunotherapy portfolio, focusing on MEDI4736, at the American...